Bicyclic compounds as dual atx/ca inhibitors
US-2018208601-A1 · Jul 26, 2018 · US
US11352330B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11352330-B2 |
| Application number | US-202016811656-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 6, 2020 |
| Priority date | Sep 4, 2015 |
| Publication date | Jun 7, 2022 |
| Grant date | Jun 7, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides novel compounds having the general formula (I)wherein RA, RB, RC, RC1 and W are as defined herein, compositions including the compounds and methods of using the compounds.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein: (1) R A is selected from the group consisting of i) C 1 -C 6 -alkyl, ii) cyano-C 1 -C 6 -alkyl, iii) C 3 -C 8 -cycloalkyl, iv) halo-C 1 -C 6 -alkoxy, v) halo-C 1 -C 6 -alkyl, vi) aryl substituted with R G , R G1 and R G2 , vii) heterocycloalkyl substituted with R G , R G1 and R G2 , and viii) heteroaryl substituted with R G , R G1 and R G2 ; and R B is selected from the group consisting of i) C 1 -C 6 -alkyl, ii) C 3 -C 8 -cycloalkyl, iii) C 1 -C 6 -alkylsulfonyl, iv) C 3 -C 8 -cycloalkylsulfonyl, v) C 1 -C 6 -alkylsulfonylamino, vi) C 3 -C 8 -cycloalkylsulfonylamino, vii) aminocarbonyl, ix) halogen, x) halo-C 1 -C 6 -alkoxy, xi) halo-C 1 -C 6 -alkyl, xii) heterocycloalkyl, and xiii) heteroaryl substituted with one H, C 1 -C 6 -alkyl, or trialkylsilyl-C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl; or (2) R A is selected from the group consisting of i) cyano-C 1 -C 6 -alkyl, ii) C 3 -C 8 -cycloalkyl, iii) halo-C 1 -C 6 -alkoxy, iv) halo-C 1 -C 6 -alkyl, v) aryl substituted with R G , R G1 and R G2 , vi) heterocycloalkyl substituted with R G , R G1 and R G2 , and vii) heteroaryl substituted with R G , R G1 and R G2 ; and R B is cyano; and: R C and R C1 are independently selected from the group consisting of i) H, ii) C 1 -C 6 -alkyl, iii) C 3 -C 8 -cycloalkyl, iv) halo-C 1 -C 6 -alkoxy, v) halo-C 1 -C 6 -alkyl, and vi) halogen; or R B and R C together with the carbon atoms to which they are attached form a ring system selected from the group consisting of i) C 3 -C 8 -cycloalkyl substituted with one to two substituent independently selected from H, C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, halo-C 1 -C 6 -alkyl and C 3 -C 8 -cycloalkyl, ii) heterocycloalkyl substituted with one to two substituent independently selected from H, C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, halo-C 1 -C 6 -alkyl and C 3 -C 8 -cycloalkyl, iii) aryl substituted with one to two substituent independently selected from H, halogen, C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, halo-C 1 -C 6 -alkyl and C 3 -C 8 -cycloalkyl, and iv) heteroaryl substituted with one to two substituent independently selected from H, halogen, C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, halo-C 1 -C 6 -alkyl, and C 3 -C 8 -cycloalkyl; W is ring system A: R D1 is selected from the group consisting of i) H, ii) C 1 -C 6 -alkyl, iii) halo-C 1 -C 6 -alkoxy, iv) halo-C 1 -C 6 -alkyl, and v) C 3 -C 8 -cycloalkyl, R G is selected from the group consisting of i) H, ii) C 1 -C 6 -alkoxy, iii) C 1 -C 6 -alkoxy-C 1 -C 6 -alkylcarbonylamino-C 1 -C 6 -alkyl, iv) C 1 -C 6 -alkoxy-C 1 -C 6 -alkylcarbonyl(C 1 -C 6 -alkyl)amino-C 1 -C 6 -alkyl, v) C 1 -C 6 -alkoxycarbonyl, vi) C 1 -C 6 -alkyl, vii) C 1 -C 6 -alkylsulfonyl, viii) C 3 -C 8 -cyloalkylsulfonyl, ix) carboxy, x) cyano, xi) C 3 -C 8 -cycloalkyl, xii) C 3 -C 8 -cycloalkoxy, xiii) C 3 -C 8 -cycloalkylcarbonylamino-C 1 -C 6 -alkyl, xiv) C 3 -C 8 -cycloalkylcarbonyl(C 1 -C 6 -alkyl)amino-C 1 -C 6 -alkyl, xv) C 1 -C 6 -alkylcarbonylamino-C 1 -C 6 -alkyl, xvi) C 1 -C 6 -alkylcarbonyl(C 1 -C 6 -alkyl)amino-C 1 -C 6 -alkyl, xvii) halo-C 1 -C 6 -alkyl, xviii) halo-C 1 -C 6 -alkoxy, xix) halogen, xx) hydroxy, xxi) aminocarbonyl substituted on the nitrogen atom with RN and Ro, xxii) aminocarbonyl-C 1 -C 6 -alkoxy substituted on the nitrogen atom with RN and Ro, xxiii) heteroaryl substituted with one H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, alkyl, halo-C 1 -C 6 -alkoxy, benzyl or aryl, wherein benzyl and aryl are substituted with one to three substituents independently selected from H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, halo-C 1 -C 6 -alkyl and halo-C 1 -C 6 -alkoxy, xxiv) heterocycloalkyl-C 1 -C 6 -alkoxy substituted with one H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, halo-C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, benzyl or aryl, wherein benzyl and aryl are substituted with one to three substituents independently selected from H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, halo-C 1 -C 6 -alkyl and halo-C 1 -C 6 -alkoxy, and xxv) heterocycloalkyl-C 1 -C 6 -alkyl substituted with one H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, halo-C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, benzyl or aryl, wherein benzyl and aryl are substituted with one to three substituents independently selected from H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, halo-C 1 -C 6 -alkyl and halo-C 1 -C 6 -alkoxy; R G1 and R G2 are independently selected from the group consisting of i) H, ii) halogen, iii) C 1 -C 6 -alkyl, iv) C 3 -C 8 -cycloalkyl, v) halo-C 1 -C 6 -alkoxy, and vi) halo-C 1 -C 6 -alkyl; R N is selected from the group consisting of i) H, ii) C 1 -C 6 -alkoxy, iii) C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, iv) C 1 -C 6 -alkoxycarbonyl-C 1 -C 6 -alkyl, v) C 1 -C 6 -alkyl, vi) carboxy-C 1 -C 6 -alkyl, vii) C 3 -C 8 -cycloalkyl, viii) C 3 -C 8 -cycloalkyl-C 1 -C 6 -alkyl, ix) hydroxy-C 1 -C 6 -alkyl, x) phenyl, and xi) heteroaryl-C 1 -C 6 -alkyl; and R O is selected from the group consisting of i) H, and ii) C 1 -C 6 -alkyl; or R N and R O together with the nitrogen atom to which they are attached form a heterocycloalkyl. 2. The compound of claim 1 , wherein the compound is: 3-[(2-tert-butyl-4-chloro-5-methylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(2-tert-butyl-4-chloro-5-fluorophenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(3,3-dimethyl-6-propan-2-yl-1,2-dihydroinden-5-yl)oxymethyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(2-tert-butyl-4-[1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]phenoxy]methyl-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-(1-methylimidazol-2-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-(1,3-oxazol-2-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(2-tert-butyl-4-morpholin-4-ylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-(3-methylimidazol-4-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(4-chloro-2-cyclopropyl-5-methylsulfonylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(2-tert-butyl-4-methylsulfonylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-[3-(2-trimethyl silyl-ethoxymethyl)imidazol-4-yl]phenoxy]-methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(4-chloro-2-cyclopropyl-5-methylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(4-chloro-2-cyclohexyl-5-methylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[4-chloro-5-methyl-2-(oxan-4-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 2-chloro-4-cyclopropyl-5-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methoxy]benzonitrile; N-[2-chloro-4-cyclopropyl-5-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]methanesulfonamide; 4-tert-butyl-3-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methoxy]benzamide; 4-methyl-3-[(5-methyl-2-propan-2-ylphenoxy)methyl]-1H-1,2,4-triazol-5-one; 3-[(4-chloro-5-methyl-2-propan-2-ylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(4-chloro-2-propan-2-ylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(6-cyclopropyl-2-methyl-1,3-benzothiazol-5-yl)oxymethyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(4-chloro-2-cyclobutyl-5-methylphenoxy
directly linked by a ring-member-to-ring-member bond · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
One oxygen atom attached in position 3 or 5 · CPC title
1,2,4-Triazoles · CPC title
with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.